SCHEMBL5609666

SCHEMBL5609666

C[C@]12CC[C@@H](O)C[C@@H]1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
G6PD P11413 4/20 0.72
SERPINA6 P08185 3/20 0.55
HIF1A Q16665 6/20 0.52
CYP3A4 P08684 6/20 0.52
HSD17B10 Q99714 5/20 0.52
NR3C1 P04150 4/20 0.52
CYP2C19 P33261 3/20 0.52
PGR P06401 3/20 0.52
KMT2A Q03164 3/20 0.52
NR3C2 P08235 2/20 0.52
MAPT P10636 2/20 0.52
SHBG P04278 1/20 0.52
NFKB1 P19838 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
ABCB11 O95342 2/20 0.52
TNF P01375 1/20 0.52
IL6 P05231 1/20 0.52
AR P10275 1/20 0.52
GLUL P15104 1/20 0.52
ADAM17 P78536 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8168541 1.00 G6PD (0.72) G6PDSERPINA6HIF1ACYP3A4HSD17B10
SCHEMBL11206109 1.00 G6PD (0.72) G6PDSERPINA6HIF1ACYP3A4HSD17B10
SCHEMBL193712 1.00 G6PD (0.72) G6PDSERPINA6HIF1ACYP3A4HSD17B10
SCHEMBL18994229 1.00 G6PD (0.72) G6PDSERPINA6HIF1ACYP3A4HSD17B10
SCHEMBL93788 1.00 G6PD (0.72) G6PDSERPINA6HIF1ACYP3A4HSD17B10
SCHEMBL29450746 1.00 G6PD (0.72) G6PDSERPINA6HIF1ACYP3A4HSD17B10
SCHEMBL2510061 1.00 G6PD (0.72) G6PDSERPINA6HIF1ACYP3A4HSD17B10
SCHEMBL21328342 1.00 G6PD (0.72) G6PDSERPINA6HIF1ACYP3A4HSD17B10
SCHEMBL21973841 1.00 G6PD (0.72) G6PDSERPINA6HIF1ACYP3A4HSD17B10
SCHEMBL14983069 0.88 G6PD (0.58) G6PDSERPINA6CYP3A4CYP2C19KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 156 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4562182-A1 BIOMARKERS FOR DIAGNOSIS AND TREATMENT OF ENDOCRINE HYPERTENSION, AND METHODS OF IDENTIFICATION THEREOF INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (FR) 2025-06-04 EP claimed
WO-2025096781-A1 METHODS AND COMPOSITIONS FOR PROVIDING CUSTOMIZED SKIN REGIMENS VIBRANT HOLDINGS, LLC (US) 2025-05-08 WO claimed
US-20240327384-A1 SALTS AND SOLID STATE FORMS OF A KIF18A INHIBITOR COMPOUND AMGEN INC. (US) 2024-10-03 US claimed
US-12085576-B2 Hybrid enzymatic aptamer sensors UNIVERSITY OF CINCINNATI (US) 2024-09-10 US claimed
CN-118459499-A Method for preparing tetrabutyl tin by using mixed solvent for Grignard reaction without sewage treatment 宁夏领世新材料科技有限公司 2024-08-09 CN claimed
CN-118356688-A Method for directly drying solvent in Grignard reaction 宁夏领世新材料科技有限公司 2024-07-19 CN claimed
CN-118272543-A Composition and method for detecting murine components in meat products based on dual Rt-RAA technology 重庆市计量质量检测研究院 2024-07-02 CN claimed
CN-117940416-A Salts and solid forms of KIF18A inhibitor compounds 安进公司 2024-04-26 CN claimed
WO-2024023324-A1 BIOMARKERS FOR DIAGNOSIS AND TREATMENT OF ENDOCRINE HYPERTENSION, AND METHODS OF IDENTIFICATION THEREOF INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (FR) 2024-02-01 WO claimed
CN-117151406-A Hierarchical control method for urban area comprehensive energy system 国网宁夏电力有限公司电力科学研究院 2023-12-01 CN claimed
CN-113701711-B High-precision positioning method and system based on Beidou positioning and barometer 宁波九纵智能科技有限公司 2023-11-03 CN claimed
EP-4097487-A1 BIOMARKERS Oxford University Innovation Limited (GB) 2022-12-07 EP claimed
CN-114018284-A Wheel speed odometer correction method based on vision 上海师范大学 2022-02-08 CN claimed
WO-2021152330-A1 BIOMARKERS OXFORD UNIVERSITY INNOVATION LIMITED (GB) 2021-08-05 WO claimed
WO-2017189528-A1 CORROSION INHIBITOR COMPOSITIONS AND METHODS OF USING SAME Ecolab USA, Inc. (US) 2017-11-02 WO claimed
US-20170306504-A1 CORROSION INHIBITOR COMPOSITIONS AND METHODS OF USING SAME CHAMPIONX LLC 2017-10-26 US claimed
US-20260109728-A1 IMMUNOMODULATING POLYNUCLEOTIDES, ANTIBODY CONJUGATES THEREOF, AND METHODS OF THEIR USE TALLAC THERAPEUTICS INC (US) 2026-04-23 US disclosed
EP-4702007-A1 INTRAVENOUS DIMETHYLTRYPTAMINE (DMT) ADMINISTRATION METHOD FOR TREATING, PREVENTING, AND/OR AMELIORATING DEPRESSION Yale University (US) 2026-03-04 EP disclosed
US-20070093460-A1 Methods of using selective 11beta-HSD inhibitors to treat gluocorticoid associated states RHODE ISLAND HOSPITAL, THE 2007-04-26 US disclosed
CN-1607954-A Pregnane steroids for the treatment of central nervous system disorders UMECRINE AB (SE) 2005-04-20 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070093460-A1 Methods of using selective 11beta-HSD inhibitors to treat gluocorticoid associated states HSD11B2, HSD11B1, HSD17B2 G6PD 114/4885SERPINA6 70/4885HIF1A 3130/4885
US-20260109728-A1 IMMUNOMODULATING POLYNUCLEOTIDES, ANTIBODY CONJUGATES THEREOF, AND METHODS OF THEIR USE UNG, DUT, TYMP G6PD 1631/4885SERPINA6 997/4885HIF1A 4592/4885
US-20240327384-A1 SALTS AND SOLID STATE FORMS OF A KIF18A INHIBITOR COMPOUND KIF18A, KIF18B, KIF15 G6PD 4331/4885SERPINA6 2710/4885HIF1A 4663/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.